Nomura Holdings’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Nomura Holdings’s Portfolio CLDI.WS Stock Details CLDI.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-467,818	Closed	-$6.08K	–	2452
2024 Q3	$6.08K	Hold	467,818	–	–	﹤0.01%	1486
2024 Q2	$19.6K	Hold	467,818	–	–	﹤0.01%	1715
2024 Q1	$24.3K	Hold	467,818	–	–	﹤0.01%	1555
2023 Q4	$0	Hold	467,818	–	–	﹤0.01%	2021
2023 Q3	$0	Hold	467,818	–	–	﹤0.01%	1692
2023 Q2	$60.8K	Hold	467,818	–	–	﹤0.01%	1242
2023 Q1	$51.5K	Hold	467,818	–	–	﹤0.01%	1332
2022 Q4	$53K	Hold	467,818	–	–	﹤0.01%	1238
2022 Q3	$62K	Hold	467,818	–	–	﹤0.01%	1356
2022 Q2	$87K	Hold	467,818	–	–	﹤0.01%	1409
2022 Q1	$196K	Buy	+467,818	New	+$206K	﹤0.01%	1583

Other funds holding CLDI.WS

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

Nomura Holdings's CLDI.WS Position: Q4 2024 in Review

Nomura Holdings sold out of Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 (CLDI.WS) in Q4 2024, closing a stake of 467,818 shares — an estimated $6.08K sold.

Nomura Holdings first reported a position in CLDI.WS in Q1 2022 and held it in 11 quarters. The position peaked at $196K in Q1 2022. 1 fund tracked by Wall St. Rank holds CLDI.WS as of Q4 2024.

Nomura Holdings reported no remaining Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 position as of Q4 2024 after selling out during the quarter.
Nomura Holdings sold 467,818 Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 shares in Q4 2024, an estimated $6.08K.
Nomura Holdings first reported a position in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in Q1 2022 and held it in 11 quarters.
Nomura Holdings's Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 position peaked at $196K in Q1 2022.
1 fund tracked by Wall St. Rank held Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 as of Q4 2024.

Based on Nomura Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.